STOCK TITAN

Community Health Systems (NYSE: CYH) EVP David Rice files initial Form 3

(Neutral)
(Neutral)
Form Type
3

Rhea-AI Filing Summary

COMMUNITY HEALTH SYSTEMS INC executive David V. Rice, who serves as EVP-Clinical Operations & CMO, filed an initial Form 3 reporting his status as an officer of the company. This filing lists no share transactions or derivative positions and shows no reported purchases or sales.

Positive

  • None.

Negative

  • None.
Buy transactions 0 transactions Form 3 transaction summary buyCount
Sell transactions 0 transactions Form 3 transaction summary sellCount
Derivative exercises 0 exercises Form 3 transaction summary exerciseCount
Net shares bought or sold 0 shares Form 3 transaction summary netBuySellShares
EVP-Clinical Operations & CMO financial
"officer_title: "EVP-Clinical Operations & CMO" for David V. Rice"
derivative transactions financial
"derivativeTransactionCount in transactionSummary is zero for this Form 3"
Derivative transactions are contracts whose value depends on the price or performance of something else—like stocks, bonds, currencies, interest rates or commodities. Think of them as insurance or bets about a future price: investors use them to protect against losses, lock in prices, or try to amplify returns, but they can also magnify losses, create cash demands and expose a firm to the risk that the other party won’t meet its obligation, so they can materially affect a company’s financial stability and volatility.
netBuySellShares financial
"transactionSummary shows netBuySellShares of 0 and direction neutral"

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
Learn about SEC filing dates

FAQ

What does David V. Rice’s Form 3 mean for COMMUNITY HEALTH SYSTEMS INC (CYH)?

The Form 3 records David V. Rice as an officer of COMMUNITY HEALTH SYSTEMS INC. It is an initial statement of ownership status and, in this case, shows no reported transactions or derivative holdings for him in the company’s securities.

Did David V. Rice buy or sell any CYH shares in this Form 3 filing?

No, this Form 3 shows no share purchases or sales by David V. Rice. The transaction summary lists zero buys, zero sells, zero exercises, and no other share movements, indicating only his reporting status as an officer.

What role does David V. Rice hold at COMMUNITY HEALTH SYSTEMS INC (CYH)?

David V. Rice is identified as an officer of COMMUNITY HEALTH SYSTEMS INC with the title EVP-Clinical Operations & CMO. This senior role is disclosed in the Form 3, which focuses on his status rather than any specific stock transactions.

Does the Form 3 for CYH show any derivative transactions for David V. Rice?

No, the Form 3 shows no derivative transactions for David V. Rice. The derivative summary is empty, and the transaction summary reports zero derivative transaction count and zero exercise shares for options or similar instruments.

Is there any net share change reported for David V. Rice in CYH stock?

No, there is no net share change reported for David V. Rice. The transaction summary shows netBuySellShares at zero and netBuySellDirection as neutral, reflecting that no buying, selling, or other share movements are reported in this filing.
SEC Form 3
FORM 3UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0104
Estimated average burden
hours per response:0.5
1. Name and Address of Reporting Person*
Rice David V.

(Last)(First)(Middle)
4000 MERIDIAN BOULEVARD

(Street)
FRANKLIN TENNESSEE 37067

(City)(State)(Zip)

UNITED STATES

(Country)
2. Date of Event Requiring Statement (Month/Day/Year)
05/12/2026
3. Issuer Name and Ticker or Trading Symbol
COMMUNITY HEALTH SYSTEMS INC [ CYH ]
3a. Foreign Trading Symbol
5. If Amendment, Date of Original Filed (Month/Day/Year)
4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director10% Owner
XOfficer (give title below)Other (specify below)
EVP-Clinical Operations & CMO
6. Individual or Joint/Group Filing (Check Applicable Line)
XForm filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4) 2. Amount of Securities Beneficially Owned (Instr. 4) 3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5) 4. Nature of Indirect Beneficial Ownership (Instr. 5)
Table II - Derivative Securities Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4) 2. Date Exercisable and Expiration Date (Month/Day/Year)3. Title and Amount of Securities Underlying Derivative Security (Instr. 4) 4. Conversion or Exercise Price of Derivative Security 5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5) 6. Nature of Indirect Beneficial Ownership (Instr. 5)
Date ExercisableExpiration DateTitleAmount or Number of Shares
Explanation of Responses:
No securities are beneficially owned.
Christopher G. Cobb, Attorney in Fact for David V. Rice05/14/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 3: SEC 1473 (03-26)